It was easy to miss because the U.S. presidential election has been dominating the headlines, but Mexico just moved one step closer to legalizing cannabis by the end of the year.
On November 19, 2020, Mexico’s Senate approved a groundbreaking cannabis legalization bill. If the initiative makes it through the lower house of Congress, it would create the world’s largest legal cannabis market. Continue reading “Mexico on Pace to Legalize in the Next 4 Weeks – Here’s How to Play It”
The northeast region of the United States is on the verge of a cannabis revolution. The shot across the bow happened on November 3, when New Jersey voted to legalize recreational cannabis.
This groundbreaking victory triggered a quick response from New York.
New York Governor Andrew Cuomo just said he wants to follow New Jersey and legalize cannabis as soon as possible to make up for COVID-related tax losses. The early word is that New York intends to legalize by April, setting the stage for sales to begin in 2022 or even sooner. Continue reading “My #1 Cannabis Stock for 2021”
The most important time of the quarter has arrived for cannabis stocks.
Earnings season is the time when companies reveal sales and earnings results for the previous quarter – and just as important, companies provide guidance on what investors should expect for the following quarter.
Quarterly earnings that beat expectations have a documented history of driving shares higher in the following weeks and months. Continue reading “77% Sales Growth Makes this Cannabis Leader a Buy”
Cannabis has emerged as a big winner in the 2020 U.S. presidential election. All five states that voted on cannabis legalization passed their ballot measures. That list includes:
This is another big step forward for the U.S. cannabis industry.
33 states have already legalized medical or recreational cannabis. Adding five more states to the mix will add billions in annual sales. The growing green wave has analysts predicting enormous growth for the U.S. cannabis industry in the next five years. Continue reading “5 States Say Yes on Cannabis – 3 Stocks to Trade the Vote”
2020 has been a great year to own technology stocks.
The NASDAQ 100 (QQQ) has gained 30% this year and many tech stocks such as Amazon (AMZN) and Apple (AAPL) traded into new all-time highs.
It makes sense. Technology is one of the few sectors that has benefited from the global quarantine as billions of consumers spend more time online.
However, while technology stocks have delivered big returns this year, the real champion of 2020 is the cannabis sector. Continue reading “3 Reasons It’s Not Too Late to Invest in Cannabis Stocks”
New York just dropped some unexpected great news on the cannabis industry this week.
If the top cannabis advisor to New York Governor Andrew Cuomo is correct, New York will legalize recreational cannabis in April. Continue reading “A $5 Billion Play on New York’s Latest Bid to Legalize”
While many international cannabis markets continue to grow at a painfully slow pace, one small Middle Eastern company is racking up a series of big wins.
Not only has Israel become the #1 importer of cannabis in the world, but it just hit a new record of medical cannabis patients. On top of that, the country is in the early stages of legalizing cannabis exports.
It’s a good time to be a cannabis company in Israel. The relatively small country of 9 million just reported three important cannabis milestones and six relatively-unknown stocks are in a position to cash in. Continue reading “6 Israeli Cannabis Stocks that Won the Export Lottery”
While the U.S. cannabis industry is one the verge of the biggest catalyst in four years, some of the most promising cannabis stocks are on sale.
Cannabis stocks performed poorly in 2019 after the young industry failed to meet investor expectations. Today that dynamic has reversed.
After poor returns in 2019, investor expectations are running low. That’s why cannabis stocks are still trading well below the 52-week high.
With election night right around the corner, the sector’s early leaders, and those with a strong presence in states that are set to cast ballots, could see explosive moves.
On top of that, these stocks are already trading far below their 52-week high and have the room to run.
Cresco Labs (CSE: CL, OTC: CRLBF) is an early leader in the U.S. cannabis industry. Headquartered in Chicago with a market cap of more than $1 billion, Cresco owns an impressive portfolio of cannabis assets. That includes 29 retail licenses, 18 dispensaries, and 15 production facilities. Cresco is positioned for long-term success in the cannabis industry.
Despite the promising outlook, Cresco shares are trading 50% below the 52-week high. We think this weakness is an opportunity to capitalize while most of the Street ignores the cannabis industry.
Cannabis Stock trades alerted its members of this awesome opportunity and sent out a trade signal for Cresco Labs on April 3. We closed that trade on July 7, securing a 50% gain in 12 weeks.
We’re still watching Cresco for our members and will add this holding back to our model portfolio when the time is right.
Green Thumb Industries (CSE: GTI, OTC: GTBIF) is another early leader in the U.S. cannabis industry.
Headquartered in Chicago, Illinois, Green Thumb has a market cap of $2.2 billion. This powerhouse company also owns and operates an impressive portfolio of cannabis assets – it operates in 12 states, owns licenses for 96 retail locations, and operates 13 manufacturing facilities.
Last quarter, Green Thumb became the first U.S. cannabis company to report revenue of more than $100 million in one quarter. Green Thumb is also positioned for long-term success in the U.S. cannabis industry.
The impressive results have been driving a big rebound on the chart. Green Thumb has rebounded close to 300% from the 52-week low in March. Despite the big rebound, Green Thumb is trading 35% below the all-time high from September of 2018.
Looking forward, Green Thumb is in a position to continue climbing as we move closer to the November election.
Curaleaf Holdings (CSE: CURL, OTC: CURLF) is the largest cannabis company in the U.S. with a market value of $4.8 billion.
Headquartered in Wakefield, Massachusetts, Curaleaf just completed a $700 million acquisition that gives it the best cannabis portfolio in the industry. That includes operations in 23 states, 135 dispensary licenses, 88 operating dispensaries, 30 processing facilities, 22 cultivation facilitates and more than 1.6 million square feet of cultivation capacity.
Curaleaf now has the best chance to be the first U.S. cannabis company to generate more than $1 billion in annual sales. After the acquisition, no other U.S. cannabis company comes close to Curaleaf’s portfolio of dispensaries, greenhouses, and processing facilities. This portfolio of cannabis assets should drive huge revenue growth in the next few years – particularly because U.S. cannabis sales are expected to surge.
The acquisition has driven a big rebound on the chart. Shares are up almost 200% since hitting a 52-week low in March. Despite the rebound, Curaleaf still has plenty of potential for more gains.
Curaleaf is in a position to deliver strong revenue growth for the next few quarters and years, and that should drive shares higher.
The key to capitalizing on these three cannabis stocks will be properly timing your entry and then knowing when to capture projects. In life (and trading), timing is everything!
Let me say it again — despite the incredible opportunity, not all cannabis stocks will do well. In fact, the cannabis industry is loaded with questionable companies that will probably fail.
Do you really have time to spend hours researching the cannabis industry, trying to separate the winning companies from ones that could implode?
Don’t waste your time! Outsource the hard work to Cannabis Stock Trades.
Get the information you need to invest in the best cannabis stocks – the ones will solid footing and massive growth potential.
Start your free trial and get:
Best,
Michael Vodicka
Editor, Cannabis Stock Trades
CannabisStockTrades.com
Author Michael Vodicka owns shares of Cresco Labs (CRLBF), Green Thumb Industries (GTBIF) and Curaleaf Holdings (CURLF).
Results are being delivered and you can see how his picks have done since inception on the website. The service has been worth every penny! – Bob P.
I am so happy that I decided to subscribe to the Cannabis Stock Trades service. It has been outstanding! I am an experienced stock trader, and I can tell you that Michael Vodicka really knows what he is doing. – Douglas W.
Thanks for the valuable insight over the last many, many months. I have made a good deal of profit following your recommendations. I am taking my profits off the table for now and waiting for a lower entry point to get back in. – Richard S.
Aurora Cannabis (ACB) just jumped 250% in two days after reporting third-quarter earnings that crushed expectations.
Not many people saw that huge jump coming. If you missed it – don’t worry.
I see a high probability that the same pattern will repeat itself on Friday morning when the largest cannabis company in the world reports highly anticipated fourth-quarter earnings.
Here’s what you need to know and how to play Friday’s big event. Continue reading “Will Canopy Growth Corp (CGC) Jump 250% in 2 Days?”
Cannabis stocks have been trapped in a terrible bear market for almost two years.
But now the tide is shifting. I think cannabis stocks have hit a long-term bottom and are now entering a new, multi-year bull market.
Why?
The cannabis industry has scored two game-changing wins in the last month. Continue reading “Cannabis Stocks Bottoming – Take a Fresh Look”